AU Stock MarketDetailed Quotes

ARX Aroa Biosurgery Ltd

Watchlist

0.655
0.0000.00%

20min DelayTrading Nov 22 16:00 AET

225.91MMarket Cap-23392P/E (Static)

Aroa Biosurgery Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 30, 2024

(FY)Mar 30, 2023

(FY)Mar 30, 2022

(FY)Mar 30, 2021

Operating cash flow (direct method)

Cash income from operating activities

17.81%62.39M

83.62%52.96M

33.14%28.84M

21.66M

Revenue from customers

22.01%59.85M

79.67%49.06M

41.33%27.3M

--19.32M

Other cash income from operating activities

-35.02%2.53M

153.73%3.9M

-34.38%1.54M

--2.34M

Cash paid

-23.53%-70.48M

-48.53%-57.06M

-48.83%-38.41M

-25.81M

Payments to suppliers for goods and services

-23.53%-70.48M

-48.53%-57.06M

-48.83%-38.41M

---25.81M

Direct dividend received

--917.347

----

Direct interest paid

---9.17K

----

-59.05%-1.25M

---783.07K

Direct interest received

44.57%1.58M

766.41%1.1M

2.76%126.41K

--123.01K

Direct tax refund paid

52.99%-248.6K

-2,894.84%-528.88K

-108.33%-17.66K

--212.06K

Operating cash flow

-91.61%-6.77M

67.03%-3.53M

-132.98%-10.71M

---4.6M

Investing cash flow

Cash flow from continuing investing activities

37.09%9.31M

120.95%6.79M

-64.21%-32.41M

-19.74M

Capital expenditure reported

-107.33%-2.59M

---1.25M

----

Net PPE purchase and sale

42.73%-3.23M

-36.29%-5.64M

-256.56%-4.14M

---1.16M

Net intangibles purchas and sale

-152.45%-590.77K

39.48%-234.02K

-79.23%-386.65K

---215.73K

Net investment purchase and sale

12.95%15.72M

149.91%13.92M

-51.87%-27.88M

---18.36M

Cash from discontinued investing activities

Investing cash flow

37.09%9.31M

120.95%6.79M

-64.21%-32.41M

---19.74M

Financing cash flow

Cash flow from continuing financing activities

-101.06%-948.54K

-101.35%-471.78K

2.70%34.98M

34.06M

Net issuance payments of debt

----

-233.64%-8.84M

--6.62M

Net common stock issuance

-101.06%-948.54K

-101.06%-471.78K

59.07%44.72M

--28.11M

Net other financing activities

----

-33.38%-895.06K

---671.07K

Cash from discontinued financing activities

Financing cash flow

-101.06%-948.54K

-101.35%-471.78K

2.70%34.98M

--34.06M

Net cash flow

Beginning cash position

51.65%8.75M

-59.63%5.77M

304.48%14.3M

--3.53M

Current changes in cash

-42.76%1.6M

134.25%2.79M

-183.73%-8.14M

--9.72M

Effect of exchange rate changes

-40.11%222K

187.46%370.68K

-149.17%-423.83K

--862.02K

End cash Position

18.36%10.57M

55.85%8.93M

-59.42%5.73M

--14.12M

Free cash from

-23.63%-13.17M

30.07%-10.66M

-155.07%-15.24M

---5.97M

Accounting Standards

US-GAAP

	(FY)Mar 30, 2024	(FY)Mar 30, 2023	(FY)Mar 30, 2022	(FY)Mar 30, 2021
Operating cash flow (direct method)
Cash income from operating activities	17.81%62.39M	83.62%52.96M	33.14%28.84M	21.66M
Revenue from customers	22.01%59.85M	79.67%49.06M	41.33%27.3M	--19.32M
Other cash income from operating activities	-35.02%2.53M	153.73%3.9M	-34.38%1.54M	--2.34M
Cash paid	-23.53%-70.48M	-48.53%-57.06M	-48.83%-38.41M	-25.81M
Payments to suppliers for goods and services	-23.53%-70.48M	-48.53%-57.06M	-48.83%-38.41M	---25.81M
Direct dividend received	--917.347	----	----	----
Direct interest paid	---9.17K	----	-59.05%-1.25M	---783.07K
Direct interest received	44.57%1.58M	766.41%1.1M	2.76%126.41K	--123.01K
Direct tax refund paid	52.99%-248.6K	-2,894.84%-528.88K	-108.33%-17.66K	--212.06K
Operating cash flow	-91.61%-6.77M	67.03%-3.53M	-132.98%-10.71M	---4.6M
Investing cash flow
Cash flow from continuing investing activities	37.09%9.31M	120.95%6.79M	-64.21%-32.41M	-19.74M
Capital expenditure reported	-107.33%-2.59M	---1.25M	----	----
Net PPE purchase and sale	42.73%-3.23M	-36.29%-5.64M	-256.56%-4.14M	---1.16M
Net intangibles purchas and sale	-152.45%-590.77K	39.48%-234.02K	-79.23%-386.65K	---215.73K
Net investment purchase and sale	12.95%15.72M	149.91%13.92M	-51.87%-27.88M	---18.36M
Cash from discontinued investing activities
Investing cash flow	37.09%9.31M	120.95%6.79M	-64.21%-32.41M	---19.74M
Financing cash flow
Cash flow from continuing financing activities	-101.06%-948.54K	-101.35%-471.78K	2.70%34.98M	34.06M
Net issuance payments of debt	----	----	-233.64%-8.84M	--6.62M
Net common stock issuance	-101.06%-948.54K	-101.06%-471.78K	59.07%44.72M	--28.11M
Net other financing activities	----	----	-33.38%-895.06K	---671.07K
Cash from discontinued financing activities
Financing cash flow	-101.06%-948.54K	-101.35%-471.78K	2.70%34.98M	--34.06M
Net cash flow
Beginning cash position	51.65%8.75M	-59.63%5.77M	304.48%14.3M	--3.53M
Current changes in cash	-42.76%1.6M	134.25%2.79M	-183.73%-8.14M	--9.72M
Effect of exchange rate changes	-40.11%222K	187.46%370.68K	-149.17%-423.83K	--862.02K
End cash Position	18.36%10.57M	55.85%8.93M	-59.42%5.73M	--14.12M
Free cash from	-23.63%-13.17M	30.07%-10.66M	-155.07%-15.24M	---5.97M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data